Dan Brennan
Stock Analyst at TD Cowen
(3.72)
# 575
Out of 5,182 analysts
126
Total ratings
44.79%
Success rate
9.26%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $170 → $157 | $115.39 | +36.06% | 14 | Feb 26, 2026 | |
| XGN Exagen | Maintains: Buy | $13 → $10 | $3.09 | +223.62% | 1 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $130 → $135 | $87.17 | +54.87% | 4 | Feb 20, 2026 | |
| BRKR Bruker | Maintains: Hold | $53 → $43 | $37.98 | +13.22% | 4 | Feb 13, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $18 → $19 | $23.00 | -17.39% | 6 | Feb 13, 2026 | |
| RVTY Revvity | Maintains: Buy | $120 → $124 | $90.46 | +37.08% | 4 | Feb 3, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $696 → $683 | $500.46 | +36.47% | 15 | Jan 30, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $123.67 | +13.20% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $192.99 | +39.90% | 7 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $7.92 | +51.52% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $2.07 | +238.16% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $345 → $390 | $317.65 | +22.78% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $4.44 | +102.70% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $7.94 | +51.13% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $13.40 | +11.94% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $19.20 | +66.67% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $60.05 | +83.18% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.11 | -19.61% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $44.16 | +67.57% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $203.00 | -13.79% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $175.55 | +42.41% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $47.78 | +6.74% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $13.32 | +320.42% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $166.51 | +227.91% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.35 | +1,011.11% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $106.72 | +117.39% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,335.00 | -34.08% | 3 | Oct 7, 2020 |
Agilent Technologies
Feb 26, 2026
Maintains: Buy
Price Target: $170 → $157
Current: $115.39
Upside: +36.06%
Exagen
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $3.09
Upside: +223.62%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $130 → $135
Current: $87.17
Upside: +54.87%
Bruker
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $37.98
Upside: +13.22%
10x Genomics
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $23.00
Upside: -17.39%
Revvity
Feb 3, 2026
Maintains: Buy
Price Target: $120 → $124
Current: $90.46
Upside: +37.08%
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $500.46
Upside: +36.47%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $123.67
Upside: +13.20%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $192.99
Upside: +39.90%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $7.92
Upside: +51.52%
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $2.07
Upside: +238.16%
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $317.65
Upside: +22.78%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $4.44
Upside: +102.70%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $7.94
Upside: +51.13%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $13.40
Upside: +11.94%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $19.20
Upside: +66.67%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $60.05
Upside: +83.18%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.11
Upside: -19.61%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $44.16
Upside: +67.57%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $203.00
Upside: -13.79%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $175.55
Upside: +42.41%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $47.78
Upside: +6.74%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $13.32
Upside: +320.42%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $166.51
Upside: +227.91%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.35
Upside: +1,011.11%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $106.72
Upside: +117.39%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,335.00
Upside: -34.08%